Clinical Trial

Experimental Autologous Blood Transfusion in Healthy Adults

Study Description

S-Nitrosylation (SNO) Therapy During Autologous Blood Transfusion

The Purpose of the study is to test the hypothesis that administration of an S-nitrosylating (SNO) agent can improve tissue oxygenation during transfusion of packed red blood cells (RBCs).

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - SNO

S-nitrosylating agent (SNO) Inhalation

Drug - Normal Saline

Normal Saline transfusion

Drug - Red Blood Cell

Blood transfusion (RBCs)

Additional Information

Official Study Title

Phase 1 Study of S-Nitrosylation Therapy to Improve Tissue Oxygenation During Autologous Blood Transfusion in Healthy Volunteer

Clinical Trial ID

NCT03999229

ParticipAid ID

bDkKKa